Biorepository of Biomarkers for Optimization of Microvascular Treatment of Lymphedema

Biorepository for Discovery and Validation of Biomarkers for Optimization of Microvascular Treatment of Lymphedema

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04123457

Enrollment

100

Registered

2019-10-11

Start date

2019-08-01

Completion date

2027-08-31

Last updated

2025-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema

Brief summary

Researchers are collecting information, saliva, blood and tissue from subjects with lymphedema to store for future research.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult (18+ years of age) * Ability to provide written consent * Has been diagnosed with Lymphedema

Exclusion criteria

* Under the age of 18 years old * Inability to provide written consent * Previous lymphovenous bypass or lymph node transfer surgery * Major changes occur to co-morbid conditions * Proven ICG or iodine allergy

Design outcomes

Primary

Measure	Time frame	Description
Biospecimen Acquisition	1 year	Number of biospecimens collected

Countries

United States

Outcome results